Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100,973
Closed -$3.51M 135
2020
Q4
$3.51M Hold
100,973
0.45% 51
2020
Q3
$1.75M Hold
100,973
0.26% 56
2020
Q2
$1.66M Hold
100,973
0.26% 57
2020
Q1
$916K Hold
100,973
0.17% 77
2019
Q4
$2.15M Hold
100,973
0.34% 57
2019
Q3
$2.32M Hold
100,973
0.39% 58
2019
Q2
$2.45M Sell
100,973
-2,000
-2% -$41.1K 0.43% 55
2019
Q1
$1.33M Sell
102,973
-25,455
-20% -$446K 0.24% 77
2018
Q4
$1.93M Sell
128,428
-33,062
-20% -$855K 0.36% 64
2018
Q3
$6.35M Buy
161,490
+49,600
+44% +$2.23M 1.09% 27
2018
Q2
$5.5M Buy
111,890
+40,900
+58% +$2.32M 0.97% 31
2018
Q1
$4.24M Buy
+70,990
New +$4.74M 0.8% 33

Other funds holding ADNT

Arnhold LLC's ADNT Position: Q1 2021 in Review

Arnhold LLC sold out of Adient (ADNT) in Q1 2021, closing a stake of 100,973 shares — an estimated $3.51M sold.

Arnhold LLC first reported a position in ADNT in Q1 2018 and held it in 12 quarters. The position peaked at $6.35M in Q3 2018. 300 funds tracked by Wall St. Rank hold ADNT as of Q1 2021.

  • Arnhold LLC reported no remaining Adient position as of Q1 2021 after selling out during the quarter.
  • Arnhold LLC sold 100,973 Adient shares in Q1 2021, an estimated $3.51M.
  • Arnhold LLC first reported a position in Adient in Q1 2018 and held it in 12 quarters.
  • Arnhold LLC's Adient position peaked at $6.35M in Q3 2018.
  • 300 funds tracked by Wall St. Rank held Adient as of Q1 2021.

Based on Arnhold LLC's 13F filing for Q1 2021, filed 30 Apr 2021.